IRIS
BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.370
EU - Europa 3.921
AS - Asia 2.130
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 4
Totale 11.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.285
CN - Cina 1.408
SE - Svezia 967
IE - Irlanda 961
IT - Italia 555
UA - Ucraina 512
SG - Singapore 369
FI - Finlandia 322
DE - Germania 282
TR - Turchia 273
GB - Regno Unito 195
CA - Canada 85
IN - India 31
CZ - Repubblica Ceca 27
AT - Austria 20
BE - Belgio 19
NL - Olanda 19
VN - Vietnam 17
CI - Costa d'Avorio 16
EU - Europa 15
FR - Francia 11
IR - Iran 10
HK - Hong Kong 7
JP - Giappone 7
RO - Romania 7
ES - Italia 6
RU - Federazione Russa 5
HR - Croazia 3
BR - Brasile 2
DK - Danimarca 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
GR - Grecia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NG - Nigeria 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 11.459
Salva come PNG Salva come JPEG
Città #
Chandler 1.077
Dublin 953
Beijing 496
Jacksonville 496
Boardman 394
Ashburn 364
Ann Arbor 360
Singapore 266
Izmir 264
Parma 241
Nanjing 230
Princeton 218
Dearborn 157
Wilmington 156
New York 119
San Mateo 114
Shanghai 101
Toronto 73
Kunming 70
Nanchang 67
Woodbridge 63
Shenyang 53
Hebei 49
Santa Clara 48
Hefei 44
Helsinki 43
Jiaxing 40
Milan 36
Jinan 34
Los Angeles 33
Seattle 32
Des Moines 31
Guangzhou 28
Changsha 27
Falls Church 26
Bremen 24
Tianjin 22
Houston 21
Norwalk 21
Brussels 19
Vienna 18
Abidjan 16
Brno 16
Dong Ket 16
Piacenza 15
Chicago 13
Dallas 13
Grafing 13
Mestre 13
Pune 13
Fremont 12
Zhengzhou 12
Chengdu 11
Hangzhou 11
Rome 9
Verona 9
Ardabil 8
Dortmund 8
Munich 8
Fuzhou 7
Rockville 7
Wenzhou 7
Augusta 6
Bolzano 6
Edinburgh 6
Washington 6
Amsterdam 5
Atlanta 5
Bologna 5
Fairfield 5
Istanbul 5
Leawood 5
Neviano degli Arduini 5
Ningbo 5
Redwood City 5
Tappahannock 5
Assago 4
Chongqing 4
Düsseldorf 4
Huskvarna 4
Kocaeli 4
Mumbai 4
Phoenix 4
Senigallia 4
Xian 4
Borås 3
Fort Worth 3
Frankfurt am Main 3
Haikou 3
Novellara 3
Padova 3
Prineville 3
Redmond 3
Shizuoka 3
Springfield 3
Strasbourg 3
Taiyuan 3
Taizhou 3
University Park 3
Vicopisano 3
Totale 7.320
Salva come PNG Salva come JPEG
Nome #
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 135
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 118
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 110
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 102
Metabolomic Changes after Coffee Consumption: New Paths on the Block 100
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 98
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 97
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 91
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 89
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 89
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 88
Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO (alternative cardiovascular bio-imaging markers) registry 86
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 84
Operation of Randle's cycle in patients with NIDDM 83
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 81
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 80
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria 80
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 80
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 79
Predictors of insulin sensitivity in type 2 diabetes mellitus 79
Adipocytes IGFBP-2 expression in prepubertal obese children. 79
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 76
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 76
Pathogenesis of NIDDM. A balanced overview. 76
Beta-cell function across the spectrum of glucose tolerance in obese youth. 75
Obesity and insulin resistance in man. A dose response study 75
Which is the eligible patient to be treated with pioglitazone? The expert view. 74
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 73
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 73
Phasic insulin release and metabolic regulation in type 2 diabetes 72
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 72
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 72
Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. 71
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 71
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 71
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects. The GISIR database. 71
Estimation of organ transport function for recirculating indicator dilution curves 70
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 70
A compartmental model to quantitate in vivo glucose transport in the human forearm 70
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 70
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 70
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study 69
Fasting plasma glucose variability predicts 10-year survival of Type 2 diabetic patients. The Verona Diabetes Study 69
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 69
Glucose and free fatty acid metabolism in human obesity. Relationship with insulin resistance 69
Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis. Prospective results from the Bruneck Study 68
In vivo glucose metabolism in obese and type II diabetic subjects with and without hypertension. 68
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 68
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 68
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 68
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. 68
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 68
Time dependence of the interaction between lipid and glucose in humans 67
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 67
Effects of glucosamine infusion on insulin secretion and insulin action in humans 67
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 67
Relationship between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Role of adipose tissue 66
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 66
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 66
Plasma glucose within the normal range is not associated with carotid atherosclerosis. Prospective results in subjects with normal glucose tolerance from the Bruneck Study 65
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes 65
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 65
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man 64
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 64
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 64
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 64
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? 64
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 64
Protein metabolism in human obesity: Relationship with glucose and lipid metabolism and with visceral adipose tissue. 64
Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes. Implications for treatment and monitoring of metabolic control 63
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 63
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus 63
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 62
Impact of Reference Category and Number of Traits in the Cluster on Risk of Coronary Heart Disease in Metabolic Syndrome: Prospective Data from the Bruneck Study. 62
Metabolic and hemodynamic effects of insulin on human hearts 61
Bariatric surgery or medical therapy for obesity 61
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 61
Insulin sensitivity is not impaired in Mexican-American women without a family history of diabetes 61
Muscle glucose transport and phosphorylation in type 2 diabetic, obese non-diabetic, and genetically predisposed individuals. 61
Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange 61
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 61
Glucose metabolism in obesity and type 2 diabetes 60
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 60
Metabolic and thermogenic effects of lactate infusion in humans 60
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 60
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 59
The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. 59
Insulin causes endothelial dysfunction in humans. Sites and mechanisms 59
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study 59
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 59
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. 58
Relationship between insulin and carotid atherosclerosis in the general population: The Bruneck study 58
Homeostasis Model Assessment (HOMA) closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity 58
High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. 58
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 57
Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. 57
Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population. 57
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study 57
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study 57
Estimation of blood flow heterogeneity in human skeletal muscle using intravascular tracer data: importance for modeling transcapillary exchange 57
Totale 7.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.149 0 0 110 28 145 147 191 33 131 222 42 100
2020/20211.363 4 114 173 12 134 150 136 26 226 76 205 107
2021/20221.084 92 38 24 29 47 36 143 128 55 56 18 418
2022/20233.628 357 236 158 299 401 448 23 218 1.297 17 127 47
2023/20241.399 90 136 66 50 113 334 72 96 40 49 146 207
2024/2025661 79 303 279 0 0 0 0 0 0 0 0 0
Totale 11.903